Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID‐19—Associated dyslipidemia: Implications for mechanism of impaired resolution and novel therapeutic approaches
Alexander V. Sorokin, Sotirios K. Karathanasis, Yang Zhihong, et al.
The FASEB Journal (2020) Vol. 34, Iss. 8, pp. 9843-9853
Open Access | Times Cited: 149

Showing 1-25 of 149 citing articles:

Specialized pro-resolving mediator network: an update on production and actions
Nan Chiang, Charles N. Serhan
Essays in Biochemistry (2020) Vol. 64, Iss. 3, pp. 443-462
Open Access | Times Cited: 305
Low high-density lipoprotein level is correlated with the severity of COVID-19 patients: an observational study
Guyi Wang, Quan Zhang, Xianmei Zhao, et al.
Lipids in Health and Disease (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 155
Monocytes and macrophages in COVID-19: Friends and foes
Sepideh Meidaninikjeh, Nasim Sabouni, Hadi Zare Marzouni, et al.
Life Sciences (2021) Vol. 269, pp. 119010-119010
Open Access | Times Cited: 133
Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Laura Kate Gadanec, Kristen Renee McSweeney, Tawar Qaradakhi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 992-992
Open Access | Times Cited: 133
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Sheryar Afzal, Aimi Syamima Abdul Manap, Ali Attiq, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 92
Risks and burdens of incident dyslipidaemia in long COVID: a cohort study
Evan Xu, Yan Xie, Ziyad Al‐Aly
The Lancet Diabetes & Endocrinology (2023) Vol. 11, Iss. 2, pp. 120-128
Open Access | Times Cited: 78
Epidemiology, risk factors and prognosis of cardiovascular disease in the Coronavirus Disease 2019 (COVID-19) pandemic era: a systematic review
Garyfallia Pepera, Marina-Sofia Tribali, Ladislav Baťalík, et al.
Reviews in Cardiovascular Medicine (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 69
Altered high-density lipoprotein composition and functions during severe COVID-19
Floran Bègue, Sébastien Tanaka, Zarouki Mouktadi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 90
Lipoprotein concentrations over time in the intensive care unit COVID-19 patients: Results from the ApoCOVID study
Sébastien Tanaka, Christian de Tymowski, Maksud Assadi, et al.
PLoS ONE (2020) Vol. 15, Iss. 9, pp. e0239573-e0239573
Open Access | Times Cited: 75
Lipid Profile Features and Their Associations With Disease Severity and Mortality in Patients With COVID-19
Jia Sun, Zhongli Chen, Peng Nie, et al.
Frontiers in Cardiovascular Medicine (2020) Vol. 7
Open Access | Times Cited: 75
New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection—Systematic Review
Marysia Wrona, Damian Skrypnik
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13280-13280
Open Access | Times Cited: 53
Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
Inês Ferreira, Filipa Falcato, Narcisa M. Bandarra, et al.
Molecules (2022) Vol. 27, Iss. 5, pp. 1677-1677
Open Access | Times Cited: 52
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 43
HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases
Fabrizia Bonacina, Angela Pirillo, Alberico L. Catapano, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1061-1061
Open Access | Times Cited: 48
Alterations of Lipid Profile in COVID-19: A Narrative Review
Abbas Rezaei, Sina Neshat, Kiyan Heshmat‐Ghahdarijani
Current Problems in Cardiology (2021) Vol. 47, Iss. 3, pp. 100907-100907
Open Access | Times Cited: 47
Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression
Indriwanto Sakidjan Atmosudigdo, Michael Anthonius Lim, Basuni Radi, et al.
Clinical Medicine Insights Endocrinology and Diabetes (2021) Vol. 14
Open Access | Times Cited: 46
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19
Azita H. Talasaz, Parham Sadeghipour, Maryam Aghakouchakzadeh, et al.
Journal of the American College of Cardiology (2021) Vol. 78, Iss. 16, pp. 1635-1654
Open Access | Times Cited: 45
Influence of foods and nutrients on COVID-19 recovery: A multivariate analysis of data from 170 countries using a generalized linear model
Alexandre de Fátima Cobre, Mônica Surek, Raquel de Oliveira Vilhena, et al.
Clinical Nutrition (2021) Vol. 41, Iss. 12, pp. 3077-3084
Open Access | Times Cited: 43
Alteration in the Lipid Profile and the Desaturases Activity in Patients With Severe Pneumonia by SARS-CoV-2
Israel Pérez-Torres, Verónica Guarner‐Lans, Elizabeth Soria‐Castro, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 41
Obesity and COVID-19: Mechanistic Insights From Adipose Tissue
Lili Yu, Xiaoying Zhang, Sarah Ye, et al.
The Journal of Clinical Endocrinology & Metabolism (2022) Vol. 107, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 27
SARS‐CoV‐2 induced HDL dysfunction may affect the host's response to and recovery from COVID‐19
Hayder M. Al‐kuraishy, Nawar Raad Hussien, Marwa S. Al‐Niemi, et al.
Immunity Inflammation and Disease (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 20
Role of Lipid Profile and Its Relative Ratios (Cholesterol/HDL-C, Triglyceride/HDL-C, LDL-C/HDL-C, WBC/HDL-C, and FBG/HDL-C) on Admission Predicts In-Hospital Mortality COVID-19
Jafar Mohammadshahi, Hassan Ghobadi, Golchin Matinfar, et al.
Journal of Lipids (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 19
Increase in gut permeability and oxidized ldl is associated with post-acute sequelae of SARS-CoV-2
Christian Mouchati, Jared Durieux, Sokratis N. Zisis, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
HDL proteome and apolipoproteins concentrations in severe ICU COVID-19 patients
Floran Bègue, Bryan Veeren, Philippe Rondeau, et al.
Lipids in Health and Disease (2025) Vol. 24, Iss. 1
Open Access
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
Stanisław Surma, Maciej Banach, Joanna Lewek
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top